Richard Peters Aprea Therapeutics, Inc. (APRE) insider trading activity

APRE Quotes by TradingView

Richard Peters is Director of Aprea Therapeutics, Inc.. Currently has a direct ownership of 2,074 shares of APRE, which is worth approximately $6,989. The most recent transaction as insider was on Jun 20, 2024, when has been sold 1,045 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 2.07K
0% 3M change
101.55% 12M change
Total Value Held $6,989

Richard Peters Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 20 2024
BUY
Grant, award, or other acquisition
-
1,045 Added 33.5%
2,074 Common Stock
Aug 23 2023
BUY
Grant, award, or other acquisition
-
500 Added 32.7%
1,029 Common Stock
Jul 28 2022
BUY
Grant, award, or other acquisition
-
5,995 Added 36.11%
10,605 Common Stock
Jun 30 2021
BUY
Grant, award, or other acquisition
-
4,610 Added 50.0%
4,610 Common Stock

Also insider at

YMTX
YUMANITY THERAPEUTICS, INC. Healthcare
RP

Richard Peters

Director
Boston, MA

Track Institutional and Insider Activities on APRE

Follow Aprea Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells APRE shares.

Notify only if

Insider Trading

Get notified when an Aprea Therapeutics, Inc. insider buys or sells APRE shares.

Notify only if

News

Receive news related to Aprea Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on APRE